Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Perspective
The adoption of the Declaration of Independence on July 4, 1776, marked a pivotal turn for colonists, from a fight for rights as British subjects to the…
Chairperson's File
To improve the health of individuals and communities, hospitals and health systems provide holistic care to patients and work to address all factors that…
Headline
The AHA will host a webinar June 25 at noon ET, in which leaders from Maimonides Medical Center in Brooklyn, N.Y., and Rush University Medical Center in…
Headline
The Health Resources and Services Administration Maternal and Child Health Bureau has announced grant opportunities available supporting maternal and child…
Headline
Hospital and health system leaders gathered June 17 and 18 in Washington, D.C., for U.S. News & World Report’s Healthcare of Tomorrow Conference, focusing…
Headline
Sarah Stella, M.D., director of Denver Health’s Housing Outreach, Partnerships and Engagement program, or HOPE, reveals how Denver Health is helping some of…